Hottinger, A F
Aissa, A B
Espeli, V
Squiban, D
Dunkel, N
Vargas, M I
Hundsberger, T
Mach, N
Schaller, K
Weber, D C
Bodmer, A
Dietrich, P-Y
Article History
Received: 31 January 2014
Revised: 18 March 2014
Accepted: 24 March 2014
First Online: 1 May 2014
Change Date: 27 May 2014
Change Type: Update
Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Competing interests
: Andreas F Hottinger: advisory board for MSD, Switzerland and Roche, Switzerland, and honoraria from the speakers bureau from MSD, International. Thomas Hundsberger: advisory boards for MSD, Switzerland and Roche, Switzerland. Pierre-Yves Dietrich: advisory board for Bayer, Switzerland. The other authors declare no conflict of interest.